VYGRVoyager Therapeutics, Inc.

VYGR Stock Price, Valuation & Chart | Voyager Therapeutics, Inc.

Compare

$3.540+0.11 (+3.21%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology VYGR intrinsic value VYGR calculated fair value vs price

Overview Financials Dividends Ratios

VYGR Historical price chart

VYGR Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization213.89M

PE Ratio-1.97

EPS-1.8

Trading Volume434.93K

Today's High/Low3.58/3.42

Dividend Yield0.00

52 Week High/Low5.55/2.94

Shares Outstanding60.42M

VYGR Financial Statement

VYGR Analyst ratings

VYGR Analysis & performance metrics

VYGR Company profile

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate…

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for…

VYGR Management team

Name

Position

Toby Ferguson M.D., Ph.D.

Chief Medical Officer

Todd Carter Ph.D.

Chief Scientific Officer

Michelle Quinn Smith

Chief Human Resources Officer

Krystof Bankiewicz M.D., Ph.D.

Founder

Jacquelyn Fahey Sandell Esq., J.D.

Chief Legal Officer

Trista MorrisonCEO

Chief Corporate Affairs Officer & Chief of Staff to the Chief Executive Officer

Nathan D. Jorgensen M.B.A., Ph.D.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Robin SwartzCOO

Chief Business Officer & Chief Operating Officer

Name

Position

Toby Ferguson M.D., Ph.D.

Chief Medical Officer

Todd Carter Ph.D.

Chief Scientific Officer

Michelle Quinn Smith

Chief Human Resources Officer

Krystof Bankiewicz M.D., Ph.D.

Founder

Jacquelyn Fahey Sandell Esq., J.D.

Chief Legal Officer

Trista MorrisonCEO

Chief Corporate Affairs Officer & Chief of Staff to the Chief Executive Officer

Nathan D. Jorgensen M.B.A., Ph.D.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Robin SwartzCOO

Chief Business Officer & Chief Operating Officer

Management Team

Toby Ferguson M.D., Ph.D.

Chief Medical Officer

Todd Carter Ph.D.

Chief Scientific Officer

Michelle Quinn Smith

Chief Human Resources Officer

Krystof Bankiewicz M.D., Ph.D.

Founder

Jacquelyn Fahey Sandell Esq., J.D.

Chief Legal Officer

Trista MorrisonCEO

Chief Corporate Affairs Officer & Chief of Staff to the Chief Executive Officer

Nathan D. Jorgensen M.B.A., Ph.D.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Robin SwartzCOO

Chief Business Officer & Chief Operating Officer

Management

Toby Ferguson M.D., Ph.D.

Chief Medical Officer

Todd Carter Ph.D.

Chief Scientific Officer

Michelle Quinn Smith

Chief Human Resources Officer

Krystof Bankiewicz M.D., Ph.D.

Founder

Jacquelyn Fahey Sandell Esq., J.D.

Chief Legal Officer

Trista MorrisonCEO

Chief Corporate Affairs Officer & Chief of Staff to the Chief Executive Officer

Nathan D. Jorgensen M.B.A., Ph.D.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Robin SwartzCOO

Chief Business Officer & Chief Operating Officer

Total 8 executives

VYGR Frequently asked questions

What is Voyager Therapeutics, Inc. (VYGR) Stock Price?

Current stock price of Voyager Therapeutics, Inc. (VYGR) stock is $3.540. The stock price is +3.21% higher in the session. The intraday range can be seen from this page. Volume of Voyager Therapeutics, Inc. (VYGR) stock is 434.93K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Voyager Therapeutics, Inc. (VYGR) stock price going up or down today?

The stock price of Voyager Therapeutics, Inc. (VYGR) can change with earnings, company news, and overall market sentiment. Voyager Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Voyager Therapeutics, Inc. stock expensive at its current price?

Whether Voyager Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VYGR on this page is -1.97. EPS on this page is -1.80. Compare those figures with peers and growth expectations before deciding if the current Voyager Therapeutics, Inc. price is justified.

How has the stock price of Voyager Therapeutics, Inc. (VYGR) performed historically?

Historical performance for Voyager Therapeutics, Inc. (VYGR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VYGR reacted to past earnings and market events.

Should I buy Voyager Therapeutics, Inc. (VYGR) stock, at this price?

Buying Voyager Therapeutics, Inc. (VYGR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.